Corteva reports Q3 2026 sales decline and cuts full‑year EBITDA guidance

Corteva Inc. posted third‑quarter 2026 net sales of $1.59 billion, down 9% year‑over‑year, and adjusted operating EBITDA of $222 million, a 17% decline. The company attributed the weakness to soft demand and pricing pressure in Brazil and Latin America, while noting growth in North America, EMEA and Asia‑Pacific. It revised its full‑year 2026 adjusted EBITDA outlook to a range of $1.1 billion‑$1.125 billion and its EPS guidance to $0.76‑$0.80 per share.

The lower EBITDA guidance reduces expectations for cash generation in 2026, which may affect dividend sustainability and capital‑allocation plans, as noted by the company in its release. Analysts highlighted the guidance cut as a key driver of the share‑price decline.

  • 1Net sales for Q3 2026 were $1.59 billion, down 9% YoY.
  • 2Adjusted operating EBITDA for Q3 2026 was $222 million, down 17% YoY.
  • 3Full‑year 2026 adjusted EBITDA guidance was lowered to $1.1 billion‑$1.125 billion.
  • 4Full‑year 2026 adjusted EPS guidance was set at $0.76‑$0.80 per share.
  • 5Latin America sales fell 28% to $570 million, with volume down 24%.
  • 6North America sales rose 7% to $574 million, with volume up 19%.

Sources